| | | Improve care access with data and dashboards that identify and prioritize healthcare disparities across the patient journey. Learn how you can quickly surface health equity statistics, reporting access to care, adherence rates, and SDOH drivers.
|
|
| | | By Ayla Ellison The Fierce 50 special report shines a spotlight on 50 remarkable individuals and organizations reshaping biopharma and healthcare. Explore their profiles across five categories, each representing a pivotal aspect of the industry. |
|
|
|
| By Annalee Armstrong After a merger with MEI Pharma was unsuccessful, Infinity Pharma has filed for bankruptcy, just as executives had warned when the deal fell through. |
| By Kevin Dunleavy Eli Lilly revealed several C-Suite moves, including the retirement of diabetes and obesity chief Mike Mason, with his duties assumed by current Lilly USA president Patrik Jonsson. |
| By Fraiser Kansteiner The FDA has rejected Lilly’s investigational atopic dermatitis treatment lebrikizumab over findings uncovered during the inspection of a third-party contract manufacturing organization. |
| Tuesday, October 10, 2023 | 12pm ET / 9am PT Folate Receptor alpha (FRα) is expressed in 90% of ovarian cancers and has limited expression in normal tissue, making it an actionable therapeutic target in platinum-resistant ovarian cancer. It is therefore critical that all ovarian cancer patients now be tested for FRα expression. Join us for this webinar to take a deep dive into FOLR1 testing for ovarian cancer. Register now.
|
|
| By Conor Hale The medtech giant reported that it has found posts on various platforms looking to sell stolen medical hardware illegally, including its McGrath MAC video laryngoscopes. |
| By Gabrielle Masson The draw of Flagship Pioneering strikes again. After leaving his position as GSK’s head of R&D, John Lepore, M.D., is set to become a CEO-partner at Flagship and will helm the portfolio company’s ProFound Therapeutics. |
| By Gabrielle Masson Eli Lilly is snapping up Point Biopharma Global, acquiring the radiopharmaceutical cancer company for $1.4 billion and entrance into the therapeutic space. |
| By Zoey Becker After reaching deals with various buyers, Viatris is pulling out of women's health and selling most of its over-the-counter products. It's also offloading the active pharmaceutical ingredient business in India. With the deals, the company will transfer 10 manufacturing sites and around 6,000 employees to the new owners. |
| By Ben Adams As Novo Nordisk boosts spending on its drug-of-the-moment Wegovy, other obesity and diabetes drugs are drafting behind. |
| By Helen Floersh It’s no secret that most drugs that work in mice fail to work in men (and women). Yet thousands of animal lives and taxpayer dollars are spent on preclinical research that, in the end, offers little more than false hope. A new method for conducting preclinical studies could help change that. |
| By Joseph Keenan Hospira, a unit of Pfizer, issued a voluntary recall of sodium bicarbonate and lidocaine HCI injectables due to the possible presence of glass particles in the vials. |
Fierce podcasts Don’t miss an episode |
| | | Violence in healthcare workplaces is a growing concern, with clinicians and other workers facing alarming rates of violence on the job. In this week’s episode of “Podnosis,” Fierce Healthcare’s Anastassia Gliadkovskaya sits down with Andrea Mazzoccoli, Ph.D., the former chief nurse and quality officer for Bon Secours Mercy Health, to delve into the urgent need for comprehensive workplace violence strategies. |
|
|---|
|
|
| Tuesday, October 10, 2023 | 2pm ET / 11am PT Your field team plays a pivotal role in securing patient access. But, a persistent challenge for life sciences manufacturers is hard-to-enter formularies and rigorous utilization management (UM) practices. Join us to learn how to develop an engagement strategy that mobilizes your field team to maximize patient access and overcome UM challenges. Register now.
|
|
| Webinar Embark on an in-depth journey through the pivotal Make-Test-Decide Workflow, where collaboration and data-driven decisions play a paramount role in the intricate landscape of drug discovery. Watch now to learn how cloud implementation fosters accessibility and collaboration, revolutionizing research across locations and companies. Sponsored by: Revvity Signals |
| Research Daiichi Sankyo wanted to create a “single source of truth, the very first place you should go” for content access and rights information. How did they replace five tools with just one? Sponsored by: CCC |
| Whitepaper From uncertainty to opportunity – Use cases for life sciences organizations to tap into the power of the metaverse and generative AI Sponsored by: Cognizant |
| eBook Learn how to get better results from suboptimal biospecimens for NGS and protein analysis. Sponsored by: Covaris |
| Whitepaper Economic and regulatory factors are making biopharma supply chains more complex in the EU. This paper explores strategies that biopharma companies can use to better manage complexity, cost, and risk. Presented by: AIM, the supply chain leader for life science entrants and midsize life science companies |
| Whitepaper From Assay Development Through Large Molecule Development. Streamline your R&D workflows and gain valuable insights with our Biology Solutions Brochure. Download now to discover how to control your laboratory workflows across various assay techniques, modalities, and data types. Sponsored by: Revvity Signals |
| Whitepaper Read this paper to learn how pharmaceutical and medical device manufacturers can improve their tender and deal management, as well as how to choose a global management platform and the best practices for implementing it. Sponsored by: Cognizant |
| eBook Emulate in vivo biology with next-generation in vitro technology. Sponsored by: Emulate |
| Whitepaper Discover five creative and innovative ways to reimagine your legacy biopharma campus and unlock value. Sponsored by: JLL |
| Whitepaper Learn more about how you can improve the productivity of your research and manufacturing operations and accelerate the journey from laboratory to saving lives. Sponsored by: JLL |
| Whitepaper Learn how pharma marketers and other players in the industry can ease the way for consumers, ultimately improving health outcomes and boosting adherence in five simple steps. Sponsored by: Healthline Media |
| Whitepaper Learn how outsourcing the buffer preparation can reallocate resources to support core activities of your bioprocess production. Sponsored by: Thermo Fisher Scientific |
| Whitepaper From trial site feasibility and patient populations to data analysis, generative AI has the potential to revolutionize drug discovery and clinical trial recruitment at both the therapeutic area and indication level. Sponsored by: H1 |
| Whitepaper Learn how a GPCR-focused library with a cell-based biopanning strategy led to the discovery of 13 high-affinity and selective anti-GLP-1R antibodies with highly developable therapeutic properties. Sponsored by: Twist Bioscience |
| Whitepaper Learn how to close the knowledge gap for cancer patients by increasing awareness of important aspects of their condition, treatment options and support resources. Sponsored by: Phreesia Life Sciences |
| Whitepaper By 2030, the global demand for biologics is projected to grow at a CAGR of 8.7% and the challenges, risks, and costs of bringing large molecule products to market are growing exponentially. Sponsored by: ThermoFisher Scientific |
| | |
|
